SCHEMBL10041807

SCHEMBL10041807

CCCC(C)(CO)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20438576 0.88 LMNA (0.41) LMNAHSD17B10
SCHEMBL8459699 0.86
SCHEMBL28734974 0.78
SCHEMBL6838867 0.74 CA2 (0.32)
SCHEMBL7597768 0.73 ALDH1A1 (0.30)
SCHEMBL223234 0.73 NUDT1 (0.33)
SCHEMBL8014455 0.72
SCHEMBL16360840 0.71 LMNA (0.41) LMNAHSD17B10
SCHEMBL13182934 0.71 LMNA (0.41) LMNAHSD17B10
SCHEMBL41037 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040378-A1 Meprobromate Immunoassay RANDOX LABORATORIES LIMITED (GB) 2012-02-16 US disclosed
EP-2418492-A1 Meprobamate immunoassay Randox Laboratories Ltd. (GB) 2012-02-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040378-A1 Meprobromate Immunoassay MEP1B, CES2, MEP1A LMNA 4619/4885HSD17B10 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.